Entrada Therapeutics (TRDA) Accumulated Depreciation (2020 - 2021)
Entrada Therapeutics (TRDA) reported Accumulated Depreciation of $1.42 million for Q4 2021, up 275.6% from $377,000 a year earlier and up 34.6% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Accumulated Depreciation (2020 - 2021) Analysis & Trends
- By year, Accumulated Depreciation came in at $377,000 in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Entrada Therapeutics | 247.25 Mn | 247.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Dec 31, 2020 | 377,000.00 |
API Access
Entrada Therapeutics Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();